SNPH: A Potential Drug Target and Biomarker for Neurological Disorders

Target Name: SNPH

NCBI ID: G9751

SNPH

SNPH: A Potential Drug Target and Biomarker for Neurological Disorders

SNPH (SNPH variant 2) is a protein that is expressed in the nervous system and has been identified as a potential drug target or biomarker. The protein is a key component of the nervous system and is involved in the development and maintenance of neural connections.

SNPH is a type of transmembrane protein that is characterized by the presence of a long extracellular region and a transmembrane region. The transmembrane region is responsible for the protein's ability to interact with other proteins and molecules that are located on the outside of the membrane.

One of the key functions of SNPH is its role in the development and maintenance of neural connections. Neural connections, also known as synapses, are the connections between neurons that allow them to communicate with one another. SNPH is involved in the formation and maintenance of these connections and is thought to play a key role in the development of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.

In addition to its role in neural connections, SNPH is also involved in the regulation of other cellular processes that are important for brain function. For example, the protein is involved in the regulation of the level of neurotransmitters, such as dopamine and GABA, which are involved in the transmission of signals in the nervous system.

SNPH is also a potential drug target because of its involvement in the development and maintenance of neural connections. Drugs that can modulate the level of neurotransmitters or the structure and function of SNPH could potentially be used to treat a variety of neurological and psychiatric disorders. For example, SNPH has been shown to be involved in the development of neurodegenerative diseases and may be a useful target for treatments that can slow the progression of these diseases.

In addition to its potential as a drug target, SNPH is also a potential biomarker for a variety of neurological and psychiatric disorders. The protein is expressed in the nervous system and can be used as a marker for the presence of neurodegenerative diseases. Additionally, the protein's involvement in the regulation of cellular processes that are important for brain function makes it a potential biomarker for a wide range of disorders, including neurological and psychiatric diseases.

Overall, SNPH is a protein that is involved in a variety of cellular and neural processes that are important for brain function. Its involvement in the development and maintenance of neural connections makes it a potential drug target and biomarker for a variety of neurological and psychiatric disorders. Further research is needed to fully understand the role of SNPH in brain function and the potential of its use as a drug or biomarker.

Protein Name: Syntaphilin

Functions: Inhibits SNARE complex formation by absorbing free syntaxin-1

The "SNPH Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNPH comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets